I am a neuroradiologist with expertise in the imaging of the brain, neck, and spine. My interests lie in the advanced imaging of brain tumors using diffusion tensor, perfusion, spectroscopic and functional MRI. I work closely with the neurosurgeons, neurologists, and radiation oncologists at Memorial Sloan Kettering to bring the most advanced standard and experimental treatments to our patients.
- Clinical Expertise: Neuroradiology
- Languages Spoken: English
- Education: MD, SUNY Upstate Medical School
- Residencies: New York Hospital of Queens; St. Luke's-Roosevelt Hospital Center
- Fellowships: NYU Medical Center
- Board Certifications: Radiology; CAQ in Neuroradiology
Lu H, Pollack E, Young R, Babb JS, Johnson G, Zagzag D, Carson R, Jensen JH, Helpern JA, Law M. Predicting grade of cerebral glioma using vascular-space occupancy MR imaging. AJNR Am J Neuroradiol 2008; 29 :373
Law M, Young RJ, Babb JS, Peccerelli N, Chheang S, Gruber ML, Miller DC, Golfinos JG, Zagzag D, Johnson G. Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 2008; 247 :490
Young R, Babb J, Law M, Pollack E, Johnson G. Comparison of region-of-interest analysis with three different histogram analysis methods in the determination of perfusion metrics in patients with brain gliomas. J Magn Reson Imaging 2007; 26 :1053
Law M, Young R, Babb J, Pollack E, Johnson G. Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas. AJNR Am J Neuroradiol 2007; 28 :761
Law M, Young R, Babb J, Rad M, Sasaki T, Zagzag D, Johnson G. Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 2006; 27 :1975
Young RJ, Ghesani MV, Kagetsu NJ, Derogatis AJ. Lesion size determines accuracy of thallium-201 brain single-photon emission tomography in differentiating between intracranial malignancy and infection in AIDS patients. AJNR Am J Neuroradiol 2005; 26 :1973
Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.